Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.

Gniadecki, R

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. [electronic resource] - The British journal of dermatology Jan 2015 - 244-52 p. digital

Publication Type: Comparative Study; Journal Article

1365-2133

10.1111/bjd.13343 doi


Adalimumab
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Biological Factors--therapeutic use
Dermatologic Agents--therapeutic use
Drug Substitution
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Infliximab
Male
Prospective Studies
Psoriasis--drug therapy
Receptors, Tumor Necrosis Factor--therapeutic use
Treatment Outcome
Ustekinumab